ABVC BioPharma Announces Streamlined Vitargus® Manufacturing Process

2 years ago

New Process Improves Quality and Lowers Cost Fremont, CA, May 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ:ABVC), a…

Wave Life Sciences to Webcast Conference Call of First Quarter 2022 Financial Results on May 12, 2022

2 years ago

CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed…

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

2 years ago

Irvine, CA, May 05, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a…

SCYNEXIS to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

2 years ago

JERSEY CITY, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

Acer Therapeutics to Participate in H.C. Wainwright Global Investment Conference

2 years ago

NEWTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…

Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting

2 years ago

IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…

Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures

2 years ago

TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic verification of fusion Accelus launches…

Tecan to attend upcoming Investor Conferences

2 years ago

Männedorf, Switzerland, May 5, 2022 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will attend the…

Treace Announces Peer-Reviewed Publication of ALIGN3D™ Multicenter Prospective Clinical Data

2 years ago

PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a medical technology company…

Synthetic Biologics Announces Formation of Scientific Advisory Board to Advance Oncology Pipeline

2 years ago

Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical development strategy and extension into…